Tuataras' fleeting visit
Twenty three inquisitive young tuatara returned to Hauturu o Toi/Little Barrier Island this week after stopping over in Warkworth a few days.
2014 News
-
-
Research to enhance fertility of New Zealand dairy cows
A Victoria University of Wellington researcher is aiming to discover why some dairy cows are less fertile than others and how to overcome the disparity
-
From dirt to drugs: bioactives from soil
The discovery of penicillin in 1928 changed the course of human history. Many life-threatening infectious diseases could now be cured by a few doses of antibiotics. In the 1970s, cyclosporin was isolated from a fungus and is now widely used to prevent rejection during organ transplant operations.
-
Asthma vaccine discovery
A team of New Zealand researchers has discovered new vaccine technology that can be used to treat asthma and other allergic diseases.
-
Quality of undergraduate research recognised
Research by three Victoria University of Wellington undergraduate students has been published in Biotechnology Letters, a highly ranked international peer-reviewed journal.
-
Pioneer recognised with international award
Victoria University of Wellington researcher Professor Ken McNatty has been awarded the 2014 Pioneer Award in recognition of his outstanding contribution to the understanding of sheep and cattle reproduction.
-
All that glitters is not gold: what is the value of mineral deposits in the deep-sea?
One of the great challenges facing all societies is to achieve a balance between economic growth, sustainability and environmental integrity.
-
Promising new treatments for multiple sclerosis
New treatments for multiple sclerosis (MS) using common anti-psychotic agents have been discovered by Victoria University of Wellington researchers.
-
Rare footage captured of tuatara hatching
Extremely rare footage of a tuatara hatching has been filmed at Victoria University of Wellington.
-
Using synthetic biology to make new antibiotics
Research at Victoria University of Wellington could lead to a new generation of antibiotics, helping tackle the global issue of ‘superbugs’ that are resistant to modern medicine.